Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed and developing *** incidence of pancreatic cancer in China accounts for about a quater of the global incidence,and the epide...
详细信息
Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed and developing *** incidence of pancreatic cancer in China accounts for about a quater of the global incidence,and the epidemiological characteristics and therapeutic strategies differ due to social,economic,cultural,environmental,and public health ***-domestic guidelines do not reflect the clinicopathologic characteristics and treat-ment patterns of Chinese ***,in 2018,the Chinese Society of Clinical Oncology(CSCO)organized a panel of senior experts from all sub-specialties within the field of pancreatic oncology to compile the Chinese guidelines for the diagnosis and treatment of pancreatic *** guidelines were made based on both the Western and Eastern clinical evidence and updated every one or two *** experts made consensus judg-ments and classified evidence-based recommendations into various grades according to the regional differences,the accessibility of diagnostic and treatment resources,and health economic indexes in *** we present the latest version of the guidelines,which covers the diagnosis,treatment,and follow-up of pancreatic *** guidelines might standardize the diagnosis and treatment of pancreatic cancer in China and will encourage oncologists to design and conduct more clinical trials about pancreatic cancer.
暂无评论